Aquestive Therapeutics

Aquestive Therapeutics is a specialty pharmaceutical company that develops and commercializes differentiated drug products using its proprietary PharmFilm oral film technology. Its aim is to improve the delivery of medicines to patients with unmet needs, especially for conditions that need alternatives to injections. Its commercial portfolio includes Sympazan (clobazam) oral film. Its late-stage candidate is Anaphylm (epinephrine) sublingual film for severe allergic reactions including anaphylaxis.